Literature DB >> 29301769

Baseline PET as prognostic marker for Hodgkin?

Josée M Zijlstra1, Ronald Boellaard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29301769     DOI： 10.1182/blood-2017-11-812958

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

Authors:  Anne-Ségolène Cottereau; Irene Buvat; Salim Kanoun; Annibale Versari; Olivier Casasnovas; Stephane Chauvie; Jérôme Clerc; Andrea Gallamini; Michel Meignan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-12       Impact factor: 9.236

2.  Computed tomography-based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma.

Authors:  Maria E S Takahashi; Camila Mosci; Edna M Souza; Sérgio Q Brunetto; Cármino de Souza; Fernando V Pericole; Irene Lorand-Metze; Celso D Ramos
Journal:  Nucl Med Commun       Date:  2020-04       Impact factor: 1.698
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.